Tue06252019

Robins Global News & Noticias



  • Shipping Advice
    Shipping Advice
  • Data Recovery Review
    Data Recovery Review
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS


NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS). Such investors are advised to contact Robert S. Willoughby at @pomlaw.com">This email address is being protected from spambots. You need JavaScript enabled to view it. or 888-476-6529, ext. 9980.
The investigation concerns whether Adamas and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]In January 2018, Adamas completed a secondary public offering (“SPO”), issuing approximately 3 million shares of common stock priced at $41.50 per share.  In October 2018, Merrill Lynch released a study which cast serious doubt on the ability of Gocovri, Adamas’s treatment for dyskinesia in Parkinson’s disease patients treated with levodopa therapy, to achieve a sizeable market share and emphasized that Adamas had failed to include critical information.  In March 2019, Adamas backtracked on prior issued growth estimates and no longer made predictions regarding Gocovri’s ability to achieve a sizeable market share.  Adamas’s stock price has fallen sharply since the SPO and now trades well below the offering price.The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.


Posted: 2019-06-12 23:05:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.


Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

ADMS INVESTORS NOTICE: Lieff Cabraser Investigates Claims Against Adamas Pharmaceuticals, Inc.

Mon, 17 Jun 2019 17:17:00 GMT

SAN FRANCISCO--(Business Wire)--The law firm of Lieff Cabraser Heimann & Bernstein, LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) ...

ADMS INVESTORS NOTICE: Lieff Cabraser Investigates Claims Against Adamas Pharmaceuticals, Inc.

Mon, 17 Jun 2019 14:54:00 GMT

The law firm of Lieff Cabraser Heimann & Bernstein, LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (Nasdaq: ADMS), including investors ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS

Wed, 12 Jun 2019 16:28:00 GMT

NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (ADMS). Such investors are advised ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS

Wed, 12 Jun 2019 16:09:00 GMT

NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS). Such investors are ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS

Fri, 07 Jun 2019 15:28:00 GMT

NEW YORK, NY / ACCESSWIRE / June 7, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. ("Adamas" or the "Company") (ADMS). Such investors are advised ...

Related Bing Web Search

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Sun, 02 Jun 2019 23:57:00 GMT)

NEW YORK, NY / ACCESSWIRE / June 3, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. ("Adamas" or the "Company") (ADMS). Such investors are ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Wed, 12 Jun 2019 23:31:00 GMT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS).

Pomerantz Law Firm Investigates Claims on Behalf of ...

(Thu, 30 May 2019 22:57:00 GMT)

NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980 ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Thu, 30 May 2019 22:57:00 GMT)

NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS).

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Tue, 18 Jun 2019 01:49:00 GMT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Thu, 13 Jun 2019 04:25:00 GMT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS; Wednesday, 12 June 2019 (5 hours ago) NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS).

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Thu, 20 Jun 2019 19:47:00 GMT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS. NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS).

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Thu, 30 May 2019 19:00:00 GMT)

Press Release SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ...

(Wed, 12 Jun 2019 23:24:00 GMT)

Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (ADMS). Such investors are advised to contact Robert S. Willoughby ...

Moss Adams: Trustee filed ‘flimsy case’ in Berg litigation ...

(Fri, 25 May 2012 14:45:00 GMT)

Plaintiffs brought a flimsy case on behalf of approximately 600 investors in the Meridian Funds without doing basic due diligence into the facts allegedly supporting those claims. Moss Adams moved ...

Related News Story Videos From Youtube

HSFS: Why and How Government Leaders Can Help - Eric L. Adams


Related Videos On: HSFS: Why and How Government Leaders Can Help - Eric L. Adams


Madagascar Oil CEO says potential is "vast" with a 1.7billion barrel resource


Related Videos On: Madagascar Oil CEO says potential is "vast" with a 1.7billion barrel resource


Fall 2017 Provost's Lecture Deputy Surgeon General Rear Admiral Sylvia Trent-Adams, Ph.D


Related Videos On: Fall 2017 Provost's Lecture Deputy Surgeon General Rear Admiral Sylvia Trent-Adams, Ph.D


Investing MMT Interest Rate Effects On The Economy And The U S Dollar Is Indeterminate!


Related Videos On: Investing MMT Interest Rate Effects On The Economy And The U S Dollar Is Indeterminate!


Question 3 - Hon Amy Adams to the Minister of Finance


Related Videos On: Question 3 - Hon Amy Adams to the Minister of Finance






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.